Literature DB >> 15254029

Analysis of sequence variation among smeDEF multi drug efflux pump genes and flanking DNA from defined 16S rRNA subgroups of clinical Stenotrophomonas maltophilia isolates.

Virginia C Gould1, Aki Okazaki, Robin A Howe, Matthew B Avison.   

Abstract

OBJECTIVES: To determine the level of variation in the smeDEF efflux pump and smeT transcriptional regulator genes among three defined 16S rRNA sequence subgroups of clinical Stenotrophomonas maltophilia isolates.
METHODS: smeDEF sequencing used a PCR genome walking approach. Determination of the sequence surrounding smeDEF used a flanking primer PCR method and specific primers anchored in smeD or smeF together with random primers.
RESULTS: smeDEF is chromosomal and located in the same position in the chromosome in all three subgroups of isolates. Flanking smeD is a gene, smeT, encoding a putative transcriptional repressor for smeDEF. Variation at these loci among the isolates is considerably lower (up to 10%) than at intrinsic beta-lactamase loci (up to 30%) in the same isolates, implying greater functional constraint. The smeD-smeT intergenic region contains a highly conserved section, which maps with previously predicted promoter/operator regions, and a hypervariable untranslated region, which can be used to subgroup clinical isolates.
CONCLUSIONS: These data provide further evidence that it is possible to group clinical isolates of the inherently variable species, S. maltophilia, based on genotypic properties. Isolate D457, in which most work concerning smeDEF expression has been performed, does not fall into S. maltophilia subgroup A, which is the most typical.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15254029     DOI: 10.1093/jac/dkh367

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  10 in total

1.  Induction of L1 and L2 beta-lactamase production in Stenotrophomonas maltophilia is dependent on an AmpR-type regulator.

Authors:  Aki Okazaki; Matthew B Avison
Journal:  Antimicrob Agents Chemother       Date:  2008-01-22       Impact factor: 5.191

Review 2.  Efflux-mediated drug resistance in bacteria: an update.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2009-08-20       Impact factor: 9.546

Review 3.  Stenotrophomonas maltophilia: an emerging global opportunistic pathogen.

Authors:  Joanna S Brooke
Journal:  Clin Microbiol Rev       Date:  2012-01       Impact factor: 26.132

4.  The efflux pump SmeDEF contributes to trimethoprim-sulfamethoxazole resistance in Stenotrophomonas maltophilia.

Authors:  María Blanca Sánchez; José Luis Martínez
Journal:  Antimicrob Agents Chemother       Date:  2015-04-27       Impact factor: 5.191

5.  Polymorphic mutation frequencies of clinical and environmental Stenotrophomonas maltophilia populations.

Authors:  María Carmen Turrientes; María Rosario Baquero; María Blanca Sánchez; Sylvia Valdezate; Esther Escudero; Gabrielle Berg; Rafael Cantón; Fernando Baquero; Juan Carlos Galán; José Luis Martínez
Journal:  Appl Environ Microbiol       Date:  2010-01-22       Impact factor: 4.792

6.  Overexpression of the Efflux Pumps SmeVWX and SmeDEF Is a Major Cause of Resistance to Co-trimoxazole in Stenotrophomonas maltophilia.

Authors:  María Blanca Sánchez; José Luis Martínez
Journal:  Antimicrob Agents Chemother       Date:  2018-05-25       Impact factor: 5.191

Review 7.  Multidrug Efflux Pumps at the Crossroad between Antibiotic Resistance and Bacterial Virulence.

Authors:  Manuel Alcalde-Rico; Sara Hernando-Amado; Paula Blanco; José L Martínez
Journal:  Front Microbiol       Date:  2016-09-21       Impact factor: 5.640

8.  PCR-based rapid genotyping of Stenotrophomonas maltophilia isolates.

Authors:  Emanuela Roscetto; Francesco Rocco; M Stella Carlomagno; Mariassunta Casalino; Bianca Colonna; Raffaele Zarrilli; Pier Paolo Di Nocera
Journal:  BMC Microbiol       Date:  2008-11-24       Impact factor: 3.605

9.  The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants.

Authors:  Lisa C Crossman; Virginia C Gould; J Maxwell Dow; Georgios S Vernikos; Aki Okazaki; Mohammed Sebaihia; David Saunders; Claire Arrowsmith; Tim Carver; Nicholas Peters; Ellen Adlem; Arnaud Kerhornou; Angela Lord; Lee Murphy; Katharine Seeger; Robert Squares; Simon Rutter; Michael A Quail; Mari-Adele Rajandream; David Harris; Carol Churcher; Stephen D Bentley; Julian Parkhill; Nicholas R Thomson; Matthew B Avison
Journal:  Genome Biol       Date:  2008-04-17       Impact factor: 13.583

10.  Characterization of bacterial operons consisting of two tubulins and a kinesin-like gene by the novel Two-Step Gene Walking method.

Authors:  Martin Pilhofer; Andreas Peter Bauer; Martina Schrallhammer; Lothar Richter; Wolfgang Ludwig; Karl-Heinz Schleifer; Giulio Petroni
Journal:  Nucleic Acids Res       Date:  2007-10-16       Impact factor: 16.971

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.